HERRIOT TABUTEAU

Insider Reports History

Location
New York, NY
Signature
/s/ Nick Pizzie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HERRIOT TABUTEAU:

Company Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 7,344,500 $1,341,406,090 $182.64 05 Jan 2026 Indirect
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Performance Stock Units 28,609 $3,749,782 $131.07 24 Feb 2025 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Restricted Stock Units 28,609 $3,749,782 $131.07 21 Feb 2025 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 7,229 $1,231,677 $170.38 07 Jan 2026 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (Right to Buy) 32,410 $305,172 $3.50 07 Jan 2026 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Employee Stock Option (Right to Buy) 28,887 21 Feb 2025 Direct

Insider Reports Filed by HERRIOT TABUTEAU

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AXSM Axsome Therapeutics, Inc. 05 Jan 2026 9 -$22,763,517 4 Chief Executive Officer, Director, 10%+ Owner 07 Jan 2026, 19:00
AXSM Axsome Therapeutics, Inc. 02 Dec 2025 9 -$11,007,199 4 Chief Executive Officer, Director, 10%+ Owner 04 Dec 2025, 19:39
AXSM Axsome Therapeutics, Inc. 03 Nov 2025 9 -$20,500,878 4 Chief Executive Officer, Director, 10%+ Owner 05 Nov 2025, 19:01
AXSM Axsome Therapeutics, Inc. 06 Oct 2025 9 -$5,054,080 4 Chief Executive Officer, Director, 10%+ Owner 08 Oct 2025, 21:08
AXSM Axsome Therapeutics, Inc. 12 Sep 2025 9 -$6,857,594 4 Chief Executive Officer, Director, 10%+ Owner 16 Sep 2025, 19:36
AXSM Axsome Therapeutics, Inc. 21 Feb 2025 3 $0 4 Chief Executive Officer, Director, 10%+ Owner 25 Feb 2025, 19:51
AXSM Axsome Therapeutics, Inc. 27 Feb 2024 2 $0 4 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner 29 Feb 2024, 18:20
AXSM Axsome Therapeutics, Inc. 02 Mar 2023 2 $0 4 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner 06 Mar 2023, 17:16
AXSM Axsome Therapeutics, Inc. 04 Mar 2022 2 $0 4 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner 08 Mar 2022, 16:04